Insider Trading History of Paul Steven M


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Paul Steven M since year 2005. The trader's CIK number is 1237564. At the time of the last reporting, Paul Steven M was the President & CEO of Karuna Therapeutics, Inc. . (stock ticker symbol KRTX). See this page for all insider trading activities at Karuna Therapeutics, Inc. .

Note that in the past PAUL STEVEN M also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Paul Steven M since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-06-28 KRTX Karuna Therapeutics, Inc. Buy 10,000 23.14 231,450
2019-03-21 SAGE Sage Therapeutics, Inc. Sale 7,879 161.04 1,268,810
2019-03-18 SAGE Sage Therapeutics, Inc. Sale 3,775 161.04 607,944
2019-03-20 SAGE Sage Therapeutics, Inc. Sale 56,646 161.30 9,136,829
2019-02-25 SAGE Sage Therapeutics, Inc. Sale 2,000 161.00 322,000
2019-02-15 SAGE Sage Therapeutics, Inc. Sale 49,461 161.02 7,964,210
2019-02-19 SAGE Sage Therapeutics, Inc. Sale 1,543 161.75 249,578
2018-03-06 SAGE Sage Therapeutics, Inc. Sale 58,139 172.00 9,999,908
2016-01-14 VYGR Voyager Therapeutics, Inc. Buy 10,000 14.07 140,690
2015-09-01 SAGE Sage Therapeutics, Inc. Sale 20,000 52.40 1,047,900
2015-08-03 SAGE Sage Therapeutics, Inc. Sale 20,000 67.15 1,343,000
2015-07-01 SAGE Sage Therapeutics, Inc. Sale 20,000 69.81 1,396,300
2015-06-01 SAGE Sage Therapeutics, Inc. Sale 20,000 72.65 1,453,020
2015-05-01 BFAM Sage Therapeutics, Inc. Sale 20,000 53.31 1,066,200
2015-04-01 SAGE Sage Therapeutics, Inc. Sale 20,000 48.51 970,200
2015-01-26 ALNY Alnylam Pharmaceuticals, Inc. Buy 1,000 95.00 95,000
2015-01-02 SIAL Sigma Aldrich Corp Option Ex 684 .00 0
2014-07-23 SAGE Sage Therapeutics, Inc. Buy 10,000 18.00 180,000
2014-01-02 SIAL Sigma Aldrich Corp Option Ex 373 .00 0
2010-02-01 LLY Lilly Eli & Co Option Ex 51,249 .00 0
2008-02-04 LLY Lilly Eli & Co Sale 19,822 51.58 1,022,458
2007-05-21 LLY Lilly Eli & Co Option Ex 98,008 54.80 5,370,838
2007-05-15 LLY Lilly Eli & Co Option Ex 1,992 54.80 109,161
2007-03-12 LLY Lilly Eli & Co Sale 7,289 52.39 381,870
2007-02-12 LLY Lilly Eli & Co Sale 7,290 54.38 396,430
2007-02-08 LLY Lilly Eli & Co Sale 10,092 54.33 548,247
2006-10-20 LLY Lilly Eli & Co Sale 4,836 56.91 275,216
2006-09-15 LLY Lilly Eli & Co Option Ex 2,890 34.59 99,979
2006-04-21 LLY Lilly Eli & Co Sale 25,000 52.80 1,320,000
2006-02-02 LLY Lilly Eli & Co Sale 6,201 57.00 353,457

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Paul Steven M (President & CEO of Karuna Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month